ENTITY
Kyorin Holdings

Kyorin Holdings (4569 JP)

8
Analysis
Health Care • Japan
KYORIN Holdings, Inc. is a holding company who manages Kyorin Group including Kyorin Pharmaceutical. The Group manufactures and distributes prescription medicine and quasi-drugs, and diagnostic drugs. Kyorin also manufactures and markets medical tools and equipment, health foods, and cosmetics as well as developing medical products with other pharmaceutical companies.
more
Refresh
•04 Aug 2020 06:48

🇯🇵 JAPAN • Results & Revisions 3rd August - Capcom, K's, Kikkoman, USS, Eisai

•BEST & WORST 3rd AUGUST •The 'best' and 'worst' from yesterday's large-cap announcements came from Kyorin (4569 JP) and Japan Airlines (9201...

Logo
283 Views
Share
•22 Dec 2018 13:51

Japan Pharma - Domestic Market and Long Listed Drug Exposure

The Japanese government recently announced its decision to initiate an ad-hoc price reduction of ~4.35%, to be levied in October 2019, this will...

bullish•Kyorin Holdings
•05 Nov 2018 21:27

Kyorin 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Overall sales (ÂĄ50b) stayed flat as brisk uptake of Flutiform (+13% to ÂĄ6.1b), Desalex (+200% to ÂĄ2.8b) and Nasonex (after Merck...

•20 Oct 2018 03:44

Japanese Small-Cap Names with Consensus Changes Leading into Earning Season....

We know that historically there has been a lot of leakage leading into Earnings Season. In a different life, I remember Fuji Photo calling me in...

Logo
442 Views
Share
bullish•Kyorin Holdings
•05 Jul 2018 20:38

Drivers in Place to Ameliorate Revenue Decline, However, Reduced Gross Margins to Be the New Normal

We reiterate our “Equal-weight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings.Drivers are in place to more than...

x